title: [Comments on the review entitled "Radiobiological features of anticancer treatments involving synchrotron radiation: outcome and perspectives"].
authors.forename: H
authors.initials: H
authors.lastname: Elleaume
authors.forename: J
authors.initials: J
authors.lastname: Rousseau
authors.forename: J-F
authors.initials: JF
authors.lastname: Adam
authors.forename: F
authors.initials: F
authors.lastname: Estève
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000528:radiation effects; D002945:Cisplatin / Q000008:administration & dosage / Q000528:radiation effects; D003131:Combined Modality Therapy / Q000379:methods; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D009010:Monte Carlo Method; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D011836:Radiation Tolerance; D011879:Radiotherapy Dosage; D012062:Relative Biological Effectiveness; D017356:Synchrotrons; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D002945:Cisplatin